Lumos Pharma (LUMO) Revenue & Revenue Breakdown
Lumos Pharma Revenue Highlights
Latest Revenue (Y)
$2.05M
Latest Revenue (Q)
$488.00K
Main Segment (Y)
Royalty
Lumos Pharma Revenue by Period
Lumos Pharma Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $2.05M | 34.67% |
| 2022-12-31 | $1.52M | 562.17% |
| 2021-12-31 | $230.00K | 36.90% |
| 2020-12-31 | $168.00K | -82.05% |
| 2019-12-31 | $936.00K | -22.39% |
| 2018-12-31 | $1.21M | 209.23% |
| 2017-12-31 | $390.00K | -88.94% |
| 2016-12-31 | $3.53M | -90.24% |
| 2015-12-31 | $36.14M | -78.22% |
| 2014-12-31 | $165.95M | 15082.98% |
| 2013-12-31 | $1.09M | -35.21% |
| 2012-12-31 | $1.69M | -9.88% |
| 2011-12-31 | $1.87M | -9.96% |
| 2010-12-31 | $2.08M | 122.59% |
| 2009-12-31 | $934.00K | 47.55% |
| 2008-12-31 | $633.00K | - |
Lumos Pharma generated $2.05M in revenue during NA 2023, up 34.67% compared to the previous quarter, and up 170.07% compared to the same period a year ago.
Lumos Pharma Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $488.00K | 195.76% |
| 2024-03-31 | $165.00K | -80.02% |
| 2023-12-31 | $826.00K | 11700.00% |
| 2023-09-30 | $7.00K | -98.67% |
| 2023-06-30 | $527.00K | -23.73% |
| 2023-03-31 | $691.00K | 34.96% |
| 2022-12-31 | $512.00K | 3.02% |
| 2022-09-30 | $497.00K | 23.33% |
| 2022-06-30 | $403.00K | 263.06% |
| 2022-03-31 | $111.00K | -49.55% |
| 2021-12-31 | $220.00K | 100.00% |
| 2021-09-30 | - | -100.00% |
| 2021-06-30 | $10.00K | 100.00% |
| 2021-03-31 | - | -100.00% |
| 2020-12-31 | $40.00K | -45.95% |
| 2020-09-30 | $74.00K | 124.24% |
| 2020-06-30 | $33.00K | 57.14% |
| 2020-03-31 | $21.00K | -95.15% |
| 2019-12-31 | $433.00K | 76.02% |
| 2019-09-30 | $246.00K | 62.91% |
| 2019-06-30 | $151.00K | 42.45% |
| 2019-03-31 | $106.00K | -47.52% |
| 2018-12-31 | $202.00K | 68.33% |
| 2018-09-30 | $120.00K | -94.67% |
| 2018-06-30 | $2.25M | -77.25% |
| 2018-03-31 | $9.90M | 17578.57% |
| 2017-12-31 | $56.00K | -45.63% |
| 2017-09-30 | $103.00K | -99.01% |
| 2017-06-30 | $10.37M | 275.59% |
| 2017-03-31 | $2.76M | 433.01% |
| 2016-12-31 | $518.00K | -41.67% |
| 2016-09-30 | $888.00K | -55.86% |
| 2016-06-30 | $2.01M | -64.75% |
| 2016-03-31 | $5.71M | -25.41% |
| 2015-12-31 | $7.65M | -46.15% |
| 2015-09-30 | $14.21M | 90.85% |
| 2015-06-30 | $7.45M | -81.01% |
| 2015-03-31 | $39.20M | -76.84% |
| 2014-12-31 | $169.25M | 5942.31% |
| 2014-09-30 | $2.80M | 1221.23% |
| 2014-06-30 | $212.00K | -36.53% |
| 2014-03-31 | $334.00K | 13.61% |
| 2013-12-31 | $294.00K | 10.94% |
| 2013-09-30 | $265.00K | 14.22% |
| 2013-06-30 | $232.00K | -23.18% |
| 2013-03-31 | $302.00K | 1.00% |
| 2012-12-31 | $299.00K | -8.56% |
| 2012-09-30 | $327.00K | -44.58% |
| 2012-06-30 | $590.00K | 25.27% |
| 2012-03-31 | $471.00K | 56.48% |
| 2011-12-31 | $301.00K | -80.84% |
| 2011-09-30 | $1.57M | 192.55% |
| 2011-06-30 | $537.00K | -11.09% |
| 2011-03-31 | $604.00K | -37.99% |
| 2010-12-31 | $974.00K | 159.73% |
| 2010-09-30 | $375.00K | -43.69% |
| 2009-12-31 | $666.00K | - |
Lumos Pharma generated $488.00K in revenue during Q2 2024, up 195.76% compared to the previous quarter, and up 70.62% compared to the same period a year ago.
Lumos Pharma Revenue Breakdown
Lumos Pharma Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 |
|---|---|---|---|---|
| Royalty | $2.00M | $1.50M | $220.00K | - |
| License and Service | - | - | $10.00K | $168.00K |
Lumos Pharma's latest annual revenue breakdown by segment (product or service), as of Dec 23: Royalty (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Dec 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Jun 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Sep 19 | Jun 19 | Mar 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Royalty | $500.00K | $200.00K | $800.00K | $500.00K | $700.00K | $500.00K | $500.00K | $400.00K | $111.00K | - | - | - | - | - | - | - | - |
| License and Service | - | - | - | - | - | - | - | - | - | $10.00K | $40.00K | $74.00K | $33.00K | $21.00K | $246.00K | $151.00K | $106.00K |
| Grant | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Lumos Pharma's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Royalty (100.00%).
Lumos Pharma Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| IPSC | Century Therapeutics | $2.23M | $771.00K |
| LUMO | Lumos Pharma | $2.05M | $488.00K |
| STTK | Shattuck Labs | $1.66M | $1.61M |
| SILO | Silo Pharma | $72.10K | $18.03K |
| ANEB | Anebulo Pharmaceuticals | - | - |
| RZLT | Rezolute | - | - |
| FBRX | Forte Biosciences | - | - |
| ERAS | Erasca | - | - |
| ELYM | Eliem Therapeutics | - | - |
| PRDS | Pardes Biosciences | - | - |
| CSBR | Champions Oncology | - | - |
LUMO Revenue FAQ
What is Lumos Pharma’s yearly revenue?
Lumos Pharma's yearly revenue for 2023 was $2.05M, representing an increase of 34.67% compared to 2022. The company's yearly revenue for 2022 was $1.52M, representing an increase of 562.17% compared to 2021. LUMO's yearly revenue for 2021 was $230K, representing an increase of 36.90% compared to 2020.
What is Lumos Pharma’s quarterly revenue?
Lumos Pharma's quarterly revenue for Q2 2024 was $488K, a 195.76% increase from the previous quarter (Q1 2024), and a -7.40% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $165K, a -80.02% decrease from the previous quarter (Q4 2023), and a -76.12% decrease year-over-year (Q1 2023). LUMO's quarterly revenue for Q4 2023 was $826K, a 11700.00% increase from the previous quarter (Q3 2023), and a 61.33% increase year-over-year (Q4 2022).
What is Lumos Pharma’s revenue growth rate?
Lumos Pharma's revenue growth rate for the last 3 years (2021-2023) was 791.74%, and for the last 5 years (2019-2023) was 119.12%.
What are Lumos Pharma’s revenue streams?
Lumos Pharma's revenue streams in c 23 are Royalty
What is Lumos Pharma’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Lumos Pharma was Royalty. This segment made a revenue of $2M, representing 100.00% of the company's total revenue.